Volume 25, Number 12—December 2019
CME ACTIVITY - Research
Streptococcus suis–Associated Meningitis, Bali, Indonesia, 2014–2017
Ni Made Susilawathi, Ni Made Adi Tarini, Ni Nengah Dwi Fatmawati, Putu I.B. Mayura, Anak Agung Ayu Suryapraba, Made Subrata, Anak Agung Raka Sudewi, and Gusti Ngurah Mahardika
Table 2
Clinical signs and outcomes of patients with confirmed Streptococcus suis meningitis, Sanglah Provincial Referral Hospital, Bali, Indonesia, 2014–2017
| Variable | No. (%) patients |
|---|---|
| Sign | |
| Fever | 40 (90.9) |
| Neck stiffness | 38 (86.4) |
| Altered mental status | 38 (86.4) |
| Headache | 36 (81.8) |
| Nausea/vomiting | 13 (29.5) |
| Septic shock | 5 (11.4) |
| Sensorineural hearing loss | 4 (9.1) |
| Seizure | 3 (6.8) |
| Ataxia | 3 (6.8) |
| Hemiparesis | 3 (6.8) |
| Septic arthritis |
2 (4.5) |
| Definitive diagnosis S. suis acute bacterial meningitis with: | |
| No complications | 34 (77.3) |
| Septic shock | 5 (11.4) |
| Deafness | 3 (6.8) |
| Signs of relapse* | 2 (4.5) |
| Deafness and arthritis |
1 (2.3) |
| Outcome | |
| Full recovery | 32 (72.7) |
| Moderate disability | 7 (15.9) |
| Death | 5 (11.4) |
*Relapsed meningitis: not recovered after 14 d treatment, but responded well after prolonged (3 weeks) ceftriaxone treatment.
Page created: November 15, 2019
Page updated: November 15, 2019
Page reviewed: November 15, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.